Cargando…

Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?

Introduction: There is an association between cryptogenic strokes and patent foramen ovale (PFO), as well as between migraines with aura and PFO. The purpose of the current study was to compare shunt characteristics in the stroke and migraine populations. Methods: We retrospectively evaluated the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadrameli, Saeed S, Gadhia, Rajan R, Kabir, Rasadul, Volpi, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205877/
https://www.ncbi.nlm.nih.gov/pubmed/30405989
http://dx.doi.org/10.7759/cureus.3213
_version_ 1783366253261357056
author Sadrameli, Saeed S
Gadhia, Rajan R
Kabir, Rasadul
Volpi, John J
author_facet Sadrameli, Saeed S
Gadhia, Rajan R
Kabir, Rasadul
Volpi, John J
author_sort Sadrameli, Saeed S
collection PubMed
description Introduction: There is an association between cryptogenic strokes and patent foramen ovale (PFO), as well as between migraines with aura and PFO. The purpose of the current study was to compare shunt characteristics in the stroke and migraine populations. Methods: We retrospectively evaluated the degree of the shunt in 68 consecutive patients with cryptogenic stroke (n=33) or migraines with aura (n=35) evaluated in a single transcranial Doppler laboratory. All patients underwent an intravenous injection of agitated saline, followed by the insonation of the middle cerebral artery to determine the degree of the right-to-left shunt. We graded the shunt size according to the number of emboli: Grade I, none; Grade II, 1-10; Grade III, 11-100; and Grade IV, >100. Grades I and II were considered low-grade shunts, and Grades III and IV were considered high-grade. Results: In the 14-month study period, we found 31 high-grade shunts and 37 low-grade shunts. Among migraines with aura patients, 27 (77%) had high-grade shunts, whereas only 4 patients (12%) with cryptogenic stroke had high-grade shunts. These percentages were significantly different between groups (Fisher’s exact test, p<0.0001). Conclusions: In a standardized laboratory using uniform methods, we found a significant difference in shunt size associated with PFO between cryptogenic stroke and migraine with aura patients. We hypothesize that in migraines with aura, venous admixture with arterial blood is the main mechanism by which PFO contributes to the condition. In contrast, cryptogenic strokes associated with PFO are more likely to arise from an atrial septal clot within the PFO space.
format Online
Article
Text
id pubmed-6205877
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-62058772018-11-07 Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter? Sadrameli, Saeed S Gadhia, Rajan R Kabir, Rasadul Volpi, John J Cureus Cardiology Introduction: There is an association between cryptogenic strokes and patent foramen ovale (PFO), as well as between migraines with aura and PFO. The purpose of the current study was to compare shunt characteristics in the stroke and migraine populations. Methods: We retrospectively evaluated the degree of the shunt in 68 consecutive patients with cryptogenic stroke (n=33) or migraines with aura (n=35) evaluated in a single transcranial Doppler laboratory. All patients underwent an intravenous injection of agitated saline, followed by the insonation of the middle cerebral artery to determine the degree of the right-to-left shunt. We graded the shunt size according to the number of emboli: Grade I, none; Grade II, 1-10; Grade III, 11-100; and Grade IV, >100. Grades I and II were considered low-grade shunts, and Grades III and IV were considered high-grade. Results: In the 14-month study period, we found 31 high-grade shunts and 37 low-grade shunts. Among migraines with aura patients, 27 (77%) had high-grade shunts, whereas only 4 patients (12%) with cryptogenic stroke had high-grade shunts. These percentages were significantly different between groups (Fisher’s exact test, p<0.0001). Conclusions: In a standardized laboratory using uniform methods, we found a significant difference in shunt size associated with PFO between cryptogenic stroke and migraine with aura patients. We hypothesize that in migraines with aura, venous admixture with arterial blood is the main mechanism by which PFO contributes to the condition. In contrast, cryptogenic strokes associated with PFO are more likely to arise from an atrial septal clot within the PFO space. Cureus 2018-08-27 /pmc/articles/PMC6205877/ /pubmed/30405989 http://dx.doi.org/10.7759/cureus.3213 Text en Copyright © 2018, Sadrameli et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Sadrameli, Saeed S
Gadhia, Rajan R
Kabir, Rasadul
Volpi, John J
Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
title Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
title_full Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
title_fullStr Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
title_full_unstemmed Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
title_short Patent Foramen Ovale in Cryptogenic Stroke and Migraine with Aura: Does Size Matter?
title_sort patent foramen ovale in cryptogenic stroke and migraine with aura: does size matter?
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205877/
https://www.ncbi.nlm.nih.gov/pubmed/30405989
http://dx.doi.org/10.7759/cureus.3213
work_keys_str_mv AT sadramelisaeeds patentforamenovaleincryptogenicstrokeandmigrainewithauradoessizematter
AT gadhiarajanr patentforamenovaleincryptogenicstrokeandmigrainewithauradoessizematter
AT kabirrasadul patentforamenovaleincryptogenicstrokeandmigrainewithauradoessizematter
AT volpijohnj patentforamenovaleincryptogenicstrokeandmigrainewithauradoessizematter